SCHEMBL6985315

SCHEMBL6985315

Nc1nc(N)nc(-c2ccc(NS(=O)(=O)c3ccc4ccccc4c3)cc2)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.60
PLAU P00749 7/20 0.59
LMNA P02545 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
ALDH1A1 P00352 2/20 0.59
GAA P10253 1/20 0.59
PGR P06401 1/20 0.58
PIK3CB P42338 1/20 0.57
PTPN2 P17706 1/20 0.56
PTPN1 P18031 1/20 0.56
PTPN5 P54829 1/20 0.56
PKM P14618 1/20 0.54
PKLR P30613 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
AKT1 P31749 1/20 0.52
AKR1C3 P42330 1/20 0.51
MAPT P10636 1/20 0.51
HDAC1 Q13547 2/20 0.51
HDAC3 O15379 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983430 0.85 KEAP1 (0.61) LMNASMN1; SMN2ALDH1A1PTPN2PTPN1
SCHEMBL8279501 0.81 PLAU (0.65) ATMPLAULMNASMN1; SMN2ALDH1A1
SCHEMBL29549847 0.78 PGR (0.77) ATMPLAULMNASMN1; SMN2ALDH1A1
SCHEMBL20021987 0.78 PGR (0.77) ATMPLAULMNASMN1; SMN2ALDH1A1
SCHEMBL28396503 0.78 PGR (0.77) ATMPLAULMNASMN1; SMN2ALDH1A1
SCHEMBL6986320 0.76 TSHR (0.60) ALDH1A1PGRPTPN2PTPN1PTPN5
SCHEMBL808105 0.76 ATM (0.72) ATMPLAULMNASMN1; SMN2ALDH1A1
SCHEMBL9942088 0.76 ATM (0.72) ATMPLAULMNASMN1; SMN2ALDH1A1
SCHEMBL9942091 0.76 ATM (0.68) ATMPLAULMNASMN1; SMN2ALDH1A1
SCHEMBL20021984 0.76 ATM (0.72) ATMPLAULMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1290264-A Triazine angiogenesis inhibitors ABBOTT LAB (US) 2001-04-04 CN claimed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
CN-1290264-A Triazine angiogenesis inhibitors ABBOTT LAB (US) 2001-04-04 CN disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed